Canadian trials have just begun for a prospective coronavirus vaccine, but its Quebec-based manufacturer is already downplaying its potential impact. Dr. Bruce Clark, president and CEO of the biopharmaceutical company Medicago, cautioned observers against holding unrealistic expectations that his product — or any of the numerous vaccines in development globally — will bring…